NASDAQ:OCEA Ocean Biomedical (OCEA) Stock Price, News & Analysis → Boost your retirement with these AI payouts (From InvestorPlace) (Ad) Free OCEA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.55▼$1.7650-Day Range N/A52-Week Range N/AVolume242,645 shsAverage Volume394,346 shsMarket Capitalization$56.13 millionP/E RatioN/ADividend YieldN/APrice Target$17.63 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsHeadlinesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsCompetitorsHeadlinesOptions ChainOwnershipShort InterestSocial Media Get Ocean Biomedical alerts: Email Address Ocean Biomedical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside988.3% Upside$17.63 Price TargetShort InterestBearish8.01% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.25 out of 5 starsMedical Sector539th out of 918 stocksPharmaceutical Preparations Industry252nd out of 425 stocks 3.5 Analyst's Opinion Consensus RatingOcean Biomedical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageOcean Biomedical has received no research coverage in the past 90 days.Read more about Ocean Biomedical's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted8.01% of the float of Ocean Biomedical has been sold short.Short Interest Ratio / Days to CoverOcean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ocean Biomedical has recently increased by 8.40%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOcean Biomedical does not currently pay a dividend.Dividend GrowthOcean Biomedical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OCEA. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Ocean Biomedical this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for OCEA on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat Follows4 people have added Ocean Biomedical to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ocean Biomedical insiders have not sold or bought any company stock.Percentage Held by Insiders73.50% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.55% of the stock of Ocean Biomedical is held by institutions.Read more about Ocean Biomedical's insider trading history. Previous Next N/A Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. About Ocean BiomedicalAesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.Read More Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. OCEA Stock News HeadlinesMay 16, 2024 | globenewswire.comOcean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe DiseaseMay 2, 2024 | msn.comBest N.J. high schools in all 21 counties based on state rating scoresApril 26, 2024 | msn.comHow New England entrepreneurs are creating skincare from lobstersApril 25, 2024 | finance.yahoo.comOcean Biomedical, Inc. (OCEA)April 24, 2024 | globenewswire.comOcean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KApril 18, 2024 | msn.comMeet the 11 global world-changers in the 2024 TED Fellows cohortApril 17, 2024 | msn.comWhat’s polluting the oceans? UC San Diego to lead large study of contaminants’ source, fate and health impactsApril 16, 2024 | newsweek.comAGW-Mental Wellbeing 2024 - Mid-size companiesApril 16, 2024 | msn.comTo Help the Allied War Effort, These Scientists Got Drunk on NitrogenApril 15, 2024 | msn.comStocks Rise but Gains Limited by Rising Bond YieldsApril 15, 2024 | msn.comStocks Climb Although Iran-Israeli Tensions Remain HighApril 12, 2024 | finance.yahoo.comApheresis Market Worth $3.9 billion | MarketsandMarkets™April 3, 2024 | msn.comUniversity of Strathclyde And British Council Offer £10,000 Engineering ScholarshipApril 3, 2024 | finance.yahoo.comCough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsightApril 2, 2024 | uk.news.yahoo.com"Space debris" spotted over California skyline after rocket launchMarch 28, 2024 | msn.comRice husk can be used as a promising sustainable packaging materialMarch 28, 2024 | globenewswire.comOcean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASLMarch 20, 2024 | seekingalpha.comOcean Biomedical: Shooting Upward, But Not Somewhere I Want To Be (Rating Upgrade)March 20, 2024 | msn.comFor intermittent fasters, 4 protein-rich meals can help you stay full and energized on the goMarch 20, 2024 | finance.yahoo.comOCEA May 2024 7.500 callMarch 20, 2024 | finance.yahoo.comOCEA May 2024 2.500 putMarch 19, 2024 | msn.comHorseshoe crabs, prized by the biomedical industry for their blood, to get new protections in MassachusettsMarch 15, 2024 | yahoo.comCape Cod Poetry: Have you ever read a poem aloud? If not, you are missing good stuff.March 11, 2024 | msn.comEmpirical Research Partners 'prone to trim' chip stocks in March portfolio strategyMarch 10, 2024 | finance.yahoo.comOCEA Mar 2024 10.000 putSee More Headlines Receive OCEA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:OCEA CUSIPN/A CIK1836612 WebN/A Phone646-908-2658FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$17.63 High Stock Price Target$17.63 Low Stock Price Target$17.63 Potential Upside/Downside+988.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-960,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-287.36% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($2.26) per share Price / Book-0.72Miscellaneous Outstanding Shares34,650,000Free Float9,182,000Market Cap$56.13 million OptionableOptionable Beta1.64 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key CompetitorsReneo PharmaceuticalsNASDAQ:RPHMEquilliumNASDAQ:EQCheckpoint TherapeuticsNASDAQ:CKPTBioLineRxNASDAQ:BLRXReviva PharmaceuticalsNASDAQ:RVPHView All Competitors OCEA Stock Analysis - Frequently Asked Questions Should I buy or sell Ocean Biomedical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ocean Biomedical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OCEA shares. View OCEA analyst ratings or view top-rated stocks. What is Ocean Biomedical's stock price target for 2024? 1 brokers have issued twelve-month price targets for Ocean Biomedical's shares. Their OCEA share price targets range from $17.63 to $17.63. On average, they predict the company's share price to reach $17.63 in the next year. This suggests a possible upside of 988.3% from the stock's current price. View analysts price targets for OCEA or view top-rated stocks among Wall Street analysts. When did Ocean Biomedical IPO? Ocean Biomedical (OCEA) raised $22 million in an initial public offering on the week of April 18th 2022. The company issued 2,000,000 shares at $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO. This page (NASDAQ:OCEA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.